NCT00923507View on ClinicalTrials.gov

Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL)

RecruitingOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

May 29, 2008

Conditions
Waldenstrom MacroglobulinemiaLymphoplasmacytic LymphomaMonoclonal B-Cell LymphocytosisSmall Lymphocytic LymphomaCLL (Chronic Lymphocytic Leukemia)
Trial Locations (1)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

All Listed Sponsors
lead

National Heart, Lung, and Blood Institute (NHLBI)

NIH

NCT00923507 - Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) | Biotech Hunter | Biotech Hunter